1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2984)
  2. Meeting Abstract (2527)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (41)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (15)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5914)
  2. GSK Faculty (5697)
  3. Department of Medicine (4259)
  4. Department of Pathology and Laboratory Medicine (3037)
  5. Tow Center for Developmental Oncology (TCDO) (2613)
  6. Solid Tumor Oncology Division (2600)

More Groups

People
  1. Marc Ladanyi (1327)
  2. David Solit (779)
  3. Ross Levine (774)
  4. Michael Berger (765)
  5. Nikolaus Schultz (486)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (120)
  2. 2024 (359)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (636)
  2. Blood (495)
  3. Cancer Research (412)
  4. Modern Pathology (299)
  5. Clinical Cancer Research (268)
  6. Laboratory Investigation (263)

More Publications

Publishers
  1. American Association for Cancer Research (871)
  2. Nature Publishing Group (758)
  3. American Society of Clinical Oncology (702)
  4. American Society of Hematology (541)
  5. Elsevier Inc. (420)
  6. Nature Research (312)

More Publishers

Results (5914)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Frequency of actionable cancer predisposing germline mutations in patients with lung cancers
    Meeting Abstract

    Mukherjee, S.; Zauderer, M. G.; Ravichandran, V.; Kemel, Y.; Mandelker, D.; Pradhan, N.; Zehir, A.; Lipkin, S. M.; Srinivasan, P.; Bandlamudi, C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • FOLFCIS regimen for treatment of cancer of the anal canal
    Meeting Abstract

    Mondaca, S.; Chatila, W. K.; Hechtman, J. F.; Bates, D.; Cercek, A.; Segal, N. H.; Stadler, Z. K.; Varghese, A. M.; Berger, M. F.; Capanu, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers
    Meeting Abstract

    Li, B. T.; Makker, V.; Buonocore, D. J.; Offin, M. D.; Olah, Z. T.; Panora, E.; Shen, R.; Ho, A. L.; Yaeger, R.; Iyer, G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • The TCGA malignant pleural mesothelioma (MPM) project: VISTA expression and delineation of a novel clinical-molecular subtype of MPM
    Meeting Abstract

    Ladanyi, M.; Robinson, B. W. S.; Campbell, P. J.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Plasma cell-free DNA for noninvasive molecular profiling in high-risk stage 4 neuroblastoma
    Meeting Abstract

    Kothari, P.; Yang, J.; Berger, M. F.; Shukla, N. N.; Modak, S.; Tsui, D.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase 1 multicenter study evaluating the safety and efficacy of MHC class II-restricted MAGE-A3/A6 T-cell receptor engineered T cells (KITE-718) in patients with advanced cancers
    Meeting Abstract

    Kebriaei, P.; Klebanoff, C. A.; Creelan, B. C.; Hong, D. S.; Blumenschein, G. R.; Drakaki, A.; Tewari, A.; Thomrongsith, L.; Jiang, Y.; Jain, R. K.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with metastatic sarcoma
    Meeting Abstract

    Kelly, C. M.; Bowler, T. G.; Munhoz, R. R.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Dholakia, R.; Condy, M. M.; Singer, S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Detection of germline homologous recombination deficiency (HRD) in patients with metastatic esophagogastric (EG) cancer using clinical next generation sequencing (NGS)
    Meeting Abstract

    Janjigian, Y. Y.; Jonsson, P.; Kemel, Y.; Joseph, V.; Tuvy, Y.; Shameer, Z.; Ravichandran, V.; Zhang, L. Y.; Mandelker, D.; Ku, G. Y.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Multigene sequencing, copy number alteration detection, and survival with first-line PD-1 based therapy in patients with mucosal melanoma
    Meeting Abstract

    Gottesdiener, L. S.; Gormally, M.; Armenia, J.; El-Jalby, M.; Postow, M. A.; Callahan, M. K.; Momtaz, P.; Wolchok, J. D.; Chapman, P. B.; Schultz, N.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Tumor mutation burden (TMB) and immune- related adverse events (irAEs) compared to antibiotic (abx) use to predict for response to immune checkpoint inhibitors in esophagogastric cancer (EGC)
    Meeting Abstract

    Greally, M.; Chatila, W. K.; Margolis, M.; Hechtman, J. F.; Tuvy, Y.; Kundra, R.; Ladanyi, M.; Kelsen, D. P.; Ilson, D. H.; Berger, M. F.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save